Cargando…
Hirudin, a thrombin inhibitor, attenuates TGF-β-induced fibrosis in renal proximal tubular epithelial cells by inhibition of protease-activated receptor 1 expression via S1P/S1PR2/S1PR3 signaling
Renal interstitial fibrosis (RIF) is the final common outcome of numerous chronic kidney diseases, contributing to end-stage renal disease. Hirudin, a thrombin inhibitor, has attracted increased attention as a potential treatment approach for renal fibrosis. The present study aimed to investigate th...
Autores principales: | Lin, Qiang, Long, Chunli, Wang, Zhengang, Wang, Ronghui, Shi, Wei, Qiu, Jiwei, Mo, Junlin, Xie, Yongxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8593869/ https://www.ncbi.nlm.nih.gov/pubmed/34815755 http://dx.doi.org/10.3892/etm.2021.10924 |
Ejemplares similares
-
A novel hirudin derivative characterized with anti-platelet aggregations and thrombin inhibition
por: Mo, Wei, et al.
Publicado: (2008) -
Bivalirudin Attenuates Thrombin-Induced Endothelial Hyperpermeability via S1P/S1PR2 Category: Original Articles
por: Ye, Haowen, et al.
Publicado: (2021) -
Structural basis of RGD-hirudin binding to thrombin: Tyr(3) and five C-terminal residues are crucial for inhibiting thrombin activity
por: Huang, Yinong, et al.
Publicado: (2014) -
The effect of hirudin on antagonisting thrombin induced apoptosis of
human microvascular endothelial cells
por: Zhu, Jiangying, et al.
Publicado: (2019) -
Structures of signaling complexes of lipid receptors S1PR1 and S1PR5 reveal mechanisms of activation and drug recognition
por: Yuan, Yuan, et al.
Publicado: (2021)